Gene Pratter, federal judge overseeing Ozempic and Mounjaro trials, dies at 75

Share on facebook
Share on twitter
Share on linkedin
Share on pinterest
Share on telegram
Share on email
Share on reddit
Share on whatsapp
Share on telegram


PHILADELPHIA — Gene EK Pratter, a federal judge who oversaw several high-profile cases during her long career and was currently overseeing lawsuits involving the diabetes and weight-loss drugs Ozempic and Mounjaro, has died. She was 75 years old.

Pratter’s death was announced Friday by the United States District Court for the Eastern District of Pennsylvania. The time and cause were not disclosed.

A graduate of Stanford University and the University of Pennsylvania Law School, Pratter was appointed a federal judge by President George W. Bush in 2004. She had a particular interest in ethics and professional conduct, according to the court’s statement, and had traveled several times to former Soviet bloc countries to address judicial ethics and case management.

A panel of federal courts appointed Pratter in February to oversee several lawsuits accusing drugmakers Novo Nordisk and Eli Lilly of failing to warn people about serious side effects linked to Ozempic and Mounjaro.

Prior to her appointment to the role, Pratter served as partner and general counsel at the law firm Duane Morris LLP.



This story originally appeared on ABCNews.go.com read the full story

Support fearless, independent journalism

We are not owned by a billionaire or shareholders – our readers support us. Donate any amount over $2. BNC Global Media Group is a global news organization that delivers fearless investigative journalism to discerning readers like you! Help us to continue publishing daily.

Support us just once

We accept support of any size, at any time – you name it for $2 or more.

Related

More

1 2 3 9,595

Don't Miss

The latest |  Trump’s secret trial resumes with second week of testimony

The latest | Trump’s secret trial resumes with second week of testimony

NEW YORK — Donald Trump’s secret trial resumes on Tuesday
Microsoft shares fall more than 6% after results fall short in latest AI disappointment

Microsoft shares fall more than 6% after results fall short in latest AI disappointment

Microsoft (MSFT) announced its fiscal fourth-quarter earnings after the bell